Gastroenterologie up2date, Table of Contents Gastroenterologie up2date 2013; 09(03): 195-208DOI: 10.1055/s-0033-1344515 Leber/Galle/Pankreas © Georg Thieme Verlag KG Stuttgart · New York Medikamentös induzierte Leberschädigung Hans Christian Spangenberg Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Sgro C, Clinard F, Ouazir K et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36: 451-455 2 Björnsson ES, Bergmann OM, Björnsson HK et al. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013; 144: 1419-1425 3 De Valle MB, Av Klinteberg V, Alem N et al. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther 2006; 24: 1187-1195 4 Shapiro MA, Lewis JH. Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. Clin Liver Dis 2007; 11: 477-505 5 Larrey D. Drug-induced liver diseases. J Hepatol 2000; 32: 77-88 6 Ostapowicz G, Fontana RJ, Schiodt FV et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-954 7 Fountain FF, Tolley E, Chrisman CR et al. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic. Chest 2005; 128: 116-123 8 Lucena MI, Andrade RJ, Fernandez MC et al. Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology 2006; 44: 850-856 9 Bell LN, Chalasani N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis 2009; 29: 337-347 10 Lucena MI, Andrade RJ, Kaplowitz N et al. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology 2009; 49: 2001-2009 11 Russo MW, Galanko JA, Shrestha R et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004; 10: 1018-1023 12 Lammert C, Einarsson S, Saha C et al. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology 2008; 47: 2003-2009 13 Lammert C, Bjornsson E, Niklasson A et al. Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology 2010; 51: 615-620 14 Steele MA, Burk RF, DesPrez RM. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest 1991; 99: 465-471 15 Schmidt LE, Dalhoff K, Poulsen HE. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. Hepatology 2002; 35: 876-882 16 Lewis JH. The rational use of potentially hepatotoxic medications in patients with underlying liver disease. Expert Opin Drug Saf 2002; 1: 159-172 17 Russo MW, Watkins PB. Are patients with elevated liver tests at increased risk of drug-induced liver injury?. Gastroenterology 2004; 126: 1477-1480 18 Andrade RJ, Robles M, Ulzurrun E et al. Drug-induced liver injury: insights from genetic studies. Pharmacogenomics 2009; 10: 1467-1487 19 Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Semin Liver Dis 2009; 29: 400-411 20 Wilke RA, Lin DW, Roden DM et al. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov 2007; 6: 904-916 21 Daly AK, Donaldson PT, Bhatnagar P. DILIGEN Study; International SAE Consortium et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009; 41: 816-819 22 Larrey D, Pageaux GP. Genetic predisposition to drug-induced hepatotoxicity. J Hepatol 1997; 26: 12-21 23 Berson A, Freneaux E, Larrey D et al. Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis. J Hepatol 1994; 20: 336-342 24 Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 2002; 22: 145-155 25 Lee WM, Larrey D, Olsson R et al. Hepatic findings in long-term clinical trials of ximelagatran. Drug Saf 2005; 28: 351-370 26 Kleiner DE. The pathology of drug-induced liver injury. Semin Liver Dis 2009; 29: 364-372 27 Hayashi PH. Causality assessment in drug-induced liver injury. Semin Liver Dis 2009; 29: 348-356 28 Suzuki A, Andrade RJ, Bjornsson E et al. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work. Drug Saf 2010; 33: 503-522 29 Tajiri K, Shimizu Y. Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol 2008; 14: 6774-6785 30 Strader DB, Bacon BR, Lindsay KL et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 2002; 97: 2391-2397 31 Suk TK, Kim DJ. Drug-induced liver injury: present and future. Clin Mol Hepatol 2012; 18: 249-257 32 Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005; 42: 481-489 33 Andrade RJ, Lucena MI, Fernandez MC et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129: 512-521 34 Chun LJ, Tong MJ, Busuttil RW et al. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009; 43: 342-349 35 Andrade RJ, Lucena MI, Kaplowitz N et al. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology 2006; 44: 1581-1588 36 Bjornsson E, Kalaitzakis E, Av Klinteberg V et al. Long-term follow-up of patients with mild to moderate drug-induced liver injury. Aliment Pharmacol Ther 2007; 26: 79-85 37 Bohan TP, Helton E, McDonald I et al. Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology 2001; 56: 1405-1409 38 Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41: 1179-1197 39 Lee WM, Hynan LS, Rossaro L et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137: 856-864, 864 e1 40 Wree A, Dechêne A, Herzer K et al. Steroid and ursodesoxycholic acid combination therapy in severe drug-induced liver injury. Digestion 2011; 84: 54-59
